Clinical Trial Update: Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5% [NA]

View source ↗

Summary

A completed clinical trial evaluating a PF ophthalmic solution containing Hyaluronic Acid 0.4% and TAU 0.5% for glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• PF Ophthalmic Solution containing Hyaluronic Acid 0.4% and TAU 0.5%

Snippet

Sponsor: Fondazione G.B. Bietti, IRCCS | Conditions: Glaucoma | NA | Status: COMPLETED